| |
著者: Jean Bousquet, Peter W Hellings, Ioana Agache, Flore Amat, Isabella Annesi-Maesano, Ignacio J Ansotegui, Josep M Anto, Claus Bachert, Eric D Bateman, Anna Bedbrook, Kazi Bennoor, Mickael Bewick, Carsten Bindslev-Jensen, Sinthia Bosnic-Anticevich, Isabelle Bosse, Jan Brozek, Luisa Brussino, Giorgio W Canonica, Victoria Cardona, Thomas Casale, Alfonso M Cepeda Sarabia, Niels H Chavannes, Lorenzo Cecchi, Jaime Correia de Sousa, Elisio Costa, Alvaro A Cruz, Wienczyslawa Czarlewski, Giuseppe De Carlo, Giulia De Feo, Pascal Demoly, Philippe Devillier, Mark S Dykewicz, Yehia El-Gamal, Esben E Eller, Joao A Fonseca, Jean-François Fontaine, Wytske J Fokkens, Maria-Antonieta Guzmán, Tari Haahtela, Maddalena Illario, Juan-Carlos Ivancevich, Jocelyne Just, Igor Kaidashev, Musa Khaitov, Omer Kalayci, Thomas Keil, Ludger Klimek, Marek L Kowalski, Piotr Kuna, Violeta Kvedariene, Desiree Larenas-Linnemann, Daniel Laune, Lan T T Le, Karin Lodrup Carlsen, Olga Lourenço, Bassam Mahboub, Alpana Mair, Enrica Menditto, Branislava Milenkovic, Mario Morais-Almeida, Ralph Mösges, Joaquim Mullol, Ruth Murray, Robert Naclerio, Leyla Namazova-Baranova, Ettore Novellino, Robyn E O'Hehir, Ken Ohta, Yoshitaka Okamoto, Kimi Okubo, Gabrielle L Onorato, Susanna Palkonen, Petr Panzner, Nikos G Papadopoulos, Hae-Sim Park, Ema Paulino, Ruby Pawankar, Oliver Pfaar, Davor Plavec, Ted A Popov, Paul Potter, Emmanuel P Prokopakis, Menachem Rottem, Dermot Ryan, Johanna Salimäki, Boleslaw Samolinski, Mario Sanchez-Borges, Holger J Schunemann, Aziz Sheikh, Juan-Carlos Sisul, Rojin Rajabian-Söderlund, Talant Sooronbaev, Cristiana Stellato, Teresa To, Ana-Maria Todo-Bom, Peter-Valentin Tomazic, Sanna Toppila-Salmi, Antonio Valero, Arunas Valiulis, Erkka Valovirta, Maria-Teresa Ventura, Martin Wagenmann, De Yun Wang, Dana Wallace, Susan Waserman, Magnus Wickman, Arzu Yorgancioglu, Luo Zhang, Nanshan Zhong, Mihaela Zidarn, Torsten Zuberbier, Mobile Airways Sentinel Network (MASK) Study Group
雑誌名: J Allergy Clin Immunol. 2019 Mar;143(3):864-879. doi: 10.1016/j.jaci.2018.08.049. Epub 2018 Sep 29.
Abstract/Text
Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
PMID 30273709 J Allergy Clin Immunol. 2019 Mar;143(3):864-879. doi: 10.1016/j.jaci.2018.08.049. Epub 2018 Sep 29.
|
